NYSE · REIT - Healthcare Facilities · USD
Ventas, Inc. (VTR) Stock Analysis
Ventas, Inc. (VTR) is a REIT - Healthcare Facilities stock listed on NYSE and quoted in US Dollar.
Last Updated: October 21, 2026
Price History
No price data available
Hover for the daily close. The dotted line marks the period open.
VTR Key Statistics
As of Oct 21, 2026Trading
- Open
- $86.70
- Previous Close
- $86.49
- Day's Range
- 85.26–86.81
- 52-Week Range
- 68.15–101.60
- Volume
- 2.88M
- BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
- 0.74
Valuation
- Market Cap
- $43.80B
- P/E Ratio
- 158.11
- Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
- 108.08
- PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
- 4.93
- P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
- 6.82
- EPS (ttm)Profit attributable to each share over the last twelve months.
- 0.54
Financials (FY)
- Revenue (FY)
- $5.83B+18.47%
- Net Income (FY)
- $251.38M+209.76%
- Profit marginThe share of revenue left as profit after all costs and taxes.
- 4.09%
- Shares Outstanding
- 512.95M
- 1-Year Return
- +24.55%
Dividend and dates
- Dividend
- $2.08+2.40%
- Ex-Dividend Date
- September 30, 2026
- Earnings Date
- October 27, 2026
- Avg Volume
- 3.58M
Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.
Key facts
As of October 21, 2026, VTR closed at $85.38, +24.55% over 1 year.
Ventas, Inc. (VTR) has a market capitalization of $43.80B.
In fiscal 2025, VTR reported revenue of $5.83B.
VTR Stock Return by Calendar Year
Ventas, Inc. (VTR) 10-year return: what $10,000 became
- 1 year
- $10,000 $12,455
- +24.55%
- 5 years
- $10,000 $17,929
- +79.29%
- 10 years
- $10,000 $18,945
- +89.45%
If you had invested $10,000 in Ventas, Inc. (VTR) 10 years ago, at the close on October 21, 2016, it would have been worth $18,945 at the close on October 21, 2026: +89.45% in total, +6.60% a year, with dividends reinvested. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.
Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.
| Year | Return |
|---|---|
| 2026 (partial year) | +12.37% |
| 2025 | +35.09% |
| 2024 | +22.24% |
| 2023 | +15.06% |
| 2022 | −8.53% |
| 2021 | +7.73% |
| 2020 | −9.80% |
| 2019 | +3.43% |
| 2018 | +3.45% |
| 2017 | +0.71% |
| 2016 (partial year) | −12.42% |
As of October 21, 2026.
VTR Revenue and Earnings by Fiscal Year
FY ends December| Fiscal year | Revenue | Net income | Net margin |
|---|---|---|---|
| 2025 | $5.83B | $251.38M | 4.3% |
| 2024 | $4.92B | $81.15M | 1.6% |
| 2023 | $4.50B | −$40.97M | −0.9% |
| 2022 | $4.13B | −$47.45M | −1.1% |
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| 2025 | $5.83B | $2.41B | $857.52M | $251.38M | 4.3% |
| 2024 | $4.92B | $2.10B | $681.23M | $81.15M | 1.6% |
| 2023 | $4.50B | $1.94B | $415.51M | −$40.97M | −0.9% |
| 2022 | $4.13B | $1.85B | $483.85M | −$47.45M | −1.1% |
Annual figures as reported, in the company's reporting currency. As of December 31, 2025.
VTR Dividend History
Dividends per share, 2025 · 4 payments
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026* | $1.56 | 3 | — |
| 2025 | $1.92 | 4 | +6.7% |
| 2024 | $1.80 | 4 | +0.0% |
| 2023 | $1.80 | 4 | +0.0% |
| Year | Dividends per share | Payments | Change |
|---|---|---|---|
| 2026 (partial year) | $1.56 | 3 | — |
| 2025 | $1.92 | 4 | +6.7% |
| 2024 | $1.80 | 4 | +0.0% |
| 2023 | $1.80 | 4 | +0.0% |
| 2022 | $1.80 | 4 | +0.0% |
| 2021 | $1.80 | 4 | −16.0% |
| 2020 | $2.14 | 4 | −32.4% |
| 2019 | $3.17 | 4 | +0.3% |
| 2018 | $3.16 | 4 | +1.5% |
| 2017 | $3.12 | 4 | +301.9% |
| 2016 | $0.78 | 1 | — |
Most recent payment: $0.52 per share, ex-dividend September 30, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.
VTR Valuation vs REIT - Healthcare Facilities Median
Median of 17 stocks| Metric | VTR | REIT - Healthcare Facilities median | vs median |
|---|---|---|---|
| P/E | 158.11 | 22.28 | 7.1x the median |
| P/S ratio | 6.82 | 5.07 | 34% above |
| Profit margin | 4.09% | 8.25% | 4.2 pts below |
Medians across 17 REIT - Healthcare Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.
Recent News
Wells Fargo Maintains Overweight on Ventas, Lowers Price Target to $96
BenzingaVentas vs. Welltower: Which Senior Housing REIT Pays Retirees Better?
24/7 Wall St.Ventas (VTR) Targets Up to 17% NOI Growth and Expands Acquisition Budget to $3 Billion
YahooBarclays Maintains Equal-Weight on Ventas, Lowers Price Target to $91
BenzingaVentas (VTR) Pays Out Over 370% of Its Earnings as Dividends, So What Actually Funds It?
YahooWhy Ventas (VTR) is a Great Dividend Stock Right Now
Yahoo
All 20 articles ↓Show fewer ↑
Ventas Announces Third Quarter 2026 Earnings Release Date and Conference Call
YahooVentas: Investment-Grade Senior And Outpatient REIT, A Bet On Quality And Growth
SeekingAlphaDespite Sale, Baron Capital Maintains Outlook on Ventas (VTR)
YahooEvercore ISI Group Maintains Outperform on Ventas, Lowers Price Target to $100
BenzingaVentas (VTR) Stock May Trade At A Discount Following Its 124% Run
YahooWhy Ventas (VTR) is a Top Dividend Stock for Your Portfolio
YahooVentas Stock: Is VTR Outperforming the Real Estate Sector?
BarchartJefferies Assumes Ventas at Buy, Announces Price Target of $102
BenzingaVentas Declares Quarterly Dividend of $0.52 Per Common Share
YahooVentas (VTR) is a Top Dividend Stock Right Now: Should You Buy?
YahooScotiabank Maintains Sector Perform on Ventas, Raises Price Target to $95
BenzingaWells Fargo Maintains Overweight on Ventas, Raises Price Target to $104
BenzingaBarclays Maintains Equal-Weight on Ventas, Raises Price Target to $102
BenzingaVentas (VTR) Up 1.1% Since Last Earnings Report: Can It Continue?
Yahoo
News provided by third-party sources. Not financial advice.
Analysis
Data-derivedEvery figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.
Related REIT - Healthcare Facilities Stocks
Welltower Inc.
$168.75B
OHIOmega Healthcare Investors, Inc.
$14.19B
DOCHealthpeak Properties, Inc.
$13.10B
AHRAmerican Healthcare REIT, Inc.
$11.52B
CTRECareTrust REIT, Inc.
$8.42B
HRHealthcare Realty Trust Incorporated
$5.98B
Popular Real Estate Stocks
Prologis, Inc.
$124.04B
EQIXEquinix, Inc.
$98.18B
AMTAmerican Tower Corporation
$82.77B
SPGSimon Property Group, Inc.
$78.03B
DLRDigital Realty Trust, Inc.
$66.59B















